Drug details
Fabrazyme (agalsidase beta)
type of Enzymes, Metabolic
Fabrazyme (agalsidase beta) for intravenous infusion is a man-made form of the naturally-occurring enzyme a-galactosidase A that is used in the treatment of Fabry disease.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- itching,
- vomiting,
- diarrhea,
- fever,
- skin rash,
- pale skin,
- lightheadedness,
- chills,
- tiredness,
- stomach pain,
- chest pain,
- dizziness,
- back pain,
- headache,
- trouble swallowing,
- drowsiness,
- swelling in your hands or feet,
- chest discomfort,
- shortness of breath
- muscle pain,
- stuffy nose,
- feeling hot or cold,
- fast or slow heart rate, and
- flushing (warmth, redness, or tingly feeling),
- tight feeling in your throat,
- numbness or tingly feeling,
The following drugs are related to Fabrazyme, either as a replacement or used together:
- Elfabrio (pegunigalsidase alfa-iwxj injection)
- Galafold (migalastat capsules)